Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis

Yasuo Yoshihara, Harumoto Yamada

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder characterized by the progressive destruction of articular cartilage. Matrix metalloproteinases (MMPs) constitute a major group among the neutral proteinases that degrade the extracellular matrix of cartilage, including various types of collagen, and aggrecan. Various MMPs are highly produced in synovial fluid and in sera from patients with RA, and are reported to play a pivotal role in cartilage matrix degradation in RA. In this review we describe the members of the MMP family and their basic function, and discuss their role in cartilage destruction in RA.

Original languageEnglish
Pages (from-to)500-508
Number of pages9
JournalClinical calcium
Volume17
Issue number4
Publication statusPublished - 01-01-2007
Externally publishedYes

Fingerprint

Matrix Metalloproteinases
Cartilage
Rheumatoid Arthritis
Aggrecans
Synovial Fluid
Articular Cartilage
Extracellular Matrix
Peptide Hydrolases
Collagen
Serum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{a5354876b92b4ce6b553cf30c0344551,
title = "Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis",
abstract = "Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder characterized by the progressive destruction of articular cartilage. Matrix metalloproteinases (MMPs) constitute a major group among the neutral proteinases that degrade the extracellular matrix of cartilage, including various types of collagen, and aggrecan. Various MMPs are highly produced in synovial fluid and in sera from patients with RA, and are reported to play a pivotal role in cartilage matrix degradation in RA. In this review we describe the members of the MMP family and their basic function, and discuss their role in cartilage destruction in RA.",
author = "Yasuo Yoshihara and Harumoto Yamada",
year = "2007",
month = "1",
day = "1",
language = "English",
volume = "17",
pages = "500--508",
journal = "Clinical calcium",
issn = "0917-5857",
publisher = "Iyaku (Medicine & Drug) Journal Co",
number = "4",

}

Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis. / Yoshihara, Yasuo; Yamada, Harumoto.

In: Clinical calcium, Vol. 17, No. 4, 01.01.2007, p. 500-508.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis

AU - Yoshihara, Yasuo

AU - Yamada, Harumoto

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder characterized by the progressive destruction of articular cartilage. Matrix metalloproteinases (MMPs) constitute a major group among the neutral proteinases that degrade the extracellular matrix of cartilage, including various types of collagen, and aggrecan. Various MMPs are highly produced in synovial fluid and in sera from patients with RA, and are reported to play a pivotal role in cartilage matrix degradation in RA. In this review we describe the members of the MMP family and their basic function, and discuss their role in cartilage destruction in RA.

AB - Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder characterized by the progressive destruction of articular cartilage. Matrix metalloproteinases (MMPs) constitute a major group among the neutral proteinases that degrade the extracellular matrix of cartilage, including various types of collagen, and aggrecan. Various MMPs are highly produced in synovial fluid and in sera from patients with RA, and are reported to play a pivotal role in cartilage matrix degradation in RA. In this review we describe the members of the MMP family and their basic function, and discuss their role in cartilage destruction in RA.

UR - http://www.scopus.com/inward/record.url?scp=34250182412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250182412&partnerID=8YFLogxK

M3 - Review article

VL - 17

SP - 500

EP - 508

JO - Clinical calcium

JF - Clinical calcium

SN - 0917-5857

IS - 4

ER -